Ashland Global Holdings Inc. (ASH) reported its first-quarter earnings for fiscal year 2024, revealing an adjusted earnings per share (EPS) of $0.28, surpassing the forecast of $0.24. However, the ...

Unfortunately, Novo Nordisk doesn't meet these two criteria ... In fact, management mentioned in the latest earnings call that the integration of these three sites is expected to have a low ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $52.5 to $120.0 for Novo Nordisk over the last 3 months.

Michael Harrison; Analyst; Seaport Research Partners ...

Get the Real Story Behind Every Major Earnings Report On Friday, Novo Nordisk A/S NVO released topline results from a phase 1b/2a trial with amycretin intended for once-weekly subcutaneous ...

However, $13.5 billion is still 3% less than what Lilly was hoping to receive, as stated in its Q3 earnings call guidance ... it also means that first-to-market Novo Nordisk didn't lose market ...

Novo Nordisk’s shares recovered some ground on Monday after a 27% slump on Friday in response to an underwhelming set of results from a Phase III trial of its new weight-loss drug CagriSema, but ...